Items where Author is "Hastings, I."
Jump to: Yes Number of items: 3. YesJones, S. and Kay, K. and Hodel, E. M. and Grünberg, M. and Lerch, A. and Felger, I. and Hastings, I.. (2021) Should deep-sequenced amplicons become the new gold-standard for analysing malaria drug clinical trials? Antimicrob Agents Chemother, 65 (10). e0043721. Felger, I. and Snounou, G. and Hastings, I. and Moehrle, J. J. and Beck , H.P.. (2020) PCR correction strategies for malaria drug trials: updates and clarifications. The Lancet infectious diseases, 20 (1). e20-e25. Jones, S. and Kay, K. and Hodel, E. M. and Chy, S. and Mbituyumuremyi, A. and Uwimana, A. and Menard, D. and Felger, I. and Hastings, I.. (2019) Improving methods for analysing anti-malarial drug efficacy trials : molecular correction based on length-polymorphic markers msp-1, msp-2 and glurp. Antimicrobial agents and chemotherapy, 63 (9). e00590-19. |
